These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 25387224)

  • 1. It takes the right medications to prevent a million heart attacks and strokes.
    DiNicolantonio JJ; Fuchs FD; O'Keefe JH
    Postgrad Med; 2014 Nov; 126(7):164-7. PubMed ID: 25387224
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of new stroke or new myocardial infarction or death at 39-month follow up in patients with diabetes mellitus, hypertension, or both treated with and without angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Ravipati G; Aronow WS; Ahn C; Alappat RM; McClung JA; Weiss MB
    Am J Ther; 2009; 16(1):2-4. PubMed ID: 19114876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A safe new dose of heart protection. Study shows drug can prevent attacks, strokes.
    Comarow A
    US News World Rep; 1999 Nov; 127(20):76. PubMed ID: 10623306
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials.
    McAlister FA;
    Eur Heart J; 2012 Feb; 33(4):505-14. PubMed ID: 22041554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding ACE inhibitors or ARBs to standard therapy for stable ischemic heart disease.
    Guirguis-Blake J
    Am Fam Physician; 2012 Jul; 86(1):21-3. PubMed ID: 22962909
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of ARB on prevention of atherosclerosis].
    Aoyama T; Minatoguchi S
    Nihon Rinsho; 2011 Jan; 69(1):92-9. PubMed ID: 21226267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in clinical practice.
    Barrios V; Coca A; Escobar C; Enrique R; Rincón LM
    Expert Rev Cardiovasc Ther; 2012 Feb; 10(2):159-66. PubMed ID: 22292872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New US target to prevent 1 million heart attacks and strokes.
    Lancet; 2011 Sep; 378(9797):1118. PubMed ID: 21943691
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
    Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
    J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The "Million Hearts" initiative--preventing heart attacks and strokes.
    Frieden TR; Berwick DM
    N Engl J Med; 2011 Sep; 365(13):e27. PubMed ID: 21913835
    [No Abstract]   [Full Text] [Related]  

  • 11. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical trials on protective efficacy of antihypertensive agents for organ damage due to diabetes mellitus complicated with hypertension].
    Higashiura K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():623-7. PubMed ID: 15171446
    [No Abstract]   [Full Text] [Related]  

  • 13. Quality focus: Million Hearts aims to reduce heart attacks and strokes.
    Schroeder SD
    S D Med; 2012 May; 65(5):191. PubMed ID: 22679656
    [No Abstract]   [Full Text] [Related]  

  • 14. The law of diminishing returns in clinical medicine: how much risk reduction is enough?
    Mold JW; Hamm RM; McCarthy LH
    J Am Board Fam Med; 2010; 23(3):371-5. PubMed ID: 20453183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of early treatment with captopril and metoprolol singly or together on six-month mortality and morbidity after acute myocardial infarction. Results of the RIMA (Rimodellamento Infarto Miocardico Acuto) study. The RIMA researchers.
    Coletta C; Ricci R; Ceci V; Seccareccia F; Rulli F; Mazzuca V; Putini RL; Salustri A; Bottero G; Pasquale M
    G Ital Cardiol; 1999 Feb; 29(2):115-24; discussion 125-9. PubMed ID: 10088066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study.
    de Peuter OR; Lip GY; Souverein PC; Klungel OH; de Boer A; Büller HR; Kamphuisen PW
    Eur J Heart Fail; 2011 May; 13(5):489-95. PubMed ID: 21193438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients.
    Baer JT; Sauer WH; Berlin JA; Kimmel SE
    Am J Cardiol; 2004 Aug; 94(4):479-81. PubMed ID: 15325933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiative raises use of interventions that prevent second heart attacks.
    Rollins G
    Rep Med Guidel Outcomes Res; 2000 Jul; 11(14):8-10. PubMed ID: 11771563
    [No Abstract]   [Full Text] [Related]  

  • 19. ACE inhibitors reduce heart-related death in type 2 diabetics.
    Health News; 2004 Oct; 10(10):15. PubMed ID: 15584126
    [No Abstract]   [Full Text] [Related]  

  • 20. Telmisartan shown to reduce cardiovascular death, myocardial infarction and stroke in ACE-intolerant high-risk patients.
    Cardiovasc J Afr; 2008; 19(5):275. PubMed ID: 18997991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.